ICRF-187 (ADR-529) cardioprotection against anthracycline-induced cardiotoxicity: Clinical and preclinical studies-Reference-Cited by-同舟云学术

ICRF-187 (ADR-529) cardioprotection against anthracycline-induced cardiotoxicity: Clinical and preclinical studies

Published:1992 Issue: Volume: Page:101-117
ISSN:0927-3042
Container-title:New Drugs, Concepts and Results in Cancer Chemotherapy
language:
Short-container-title:

Author:

Green Michael D.,Alderton Peggy,Sobol Mordechai M.,Gross Janet,Muggia Franco M.,Speyer James L.

Publisher

Springer US

Link

http://link.springer.com/content/pdf/10.1007/978-1-4615-3876-9_6.pdf

Reference98 articles.

1. Bachur NR, Gordon SL, and Gee MV. A general mechanism for microsomal activation of quinone anticancer agents to free radicals. Cancer Res 38:1745–1750, 1978.

2. Myers CE, McGuire WP, Liss RH, Ifrim I, et al. Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response. Science 197:165–167, 1977.

3. Thayer WS. Adriamycin stimulated superoxide formation in submitochondrial particles. Chem-Biol Inter 19:265–278, 1977.

4. Doroshow JH, Locker GY, and Myers CE. Enzymatic defenses of the mouse heart against reactive oxygen metabolites. J Clin Invest 65:128–135, 1980.

5. Bachur NR, Gordon SL, and Gee MV. Anthracycline antibiotic augmentation of microsomal electron transport and free radical formation. Mol Pharmacol 13:901–910, 1977.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fluorescence Properties of Doxorubicin-Loaded Iron Oxide Nanoparticles;Springer Proceedings in Physics;2020

2. Cardiotoxicity of Cancer Therapy;Cancer Investigation;1999-01

3. The prevention of anthracycline cardiomyopathy;Progress in Pediatric Cardiology;1998-01

4. Doxorubicin-heparin complex: reduction of cardiotoxicity of doxorubicin;Journal of Cancer Research and Clinical Oncology;1995-08